AB1579 Ultrasound joint assessments increase detection of polyarticular joint involvement in checkpoint inhibitors induced arthritis

Meric de Bellefon, Laurent;Aspeslagh, Sandrine;Aboubakar Nana, Frank;Baurain, Jean-François;Durez, Patrick
(2023) EULAR 2023 European Congress of Rheumatology — Location: (Italy) Milano (31.May.2023)

Files

2023_EULAR_AB1579.pdf
  • Open Access
  • Adobe PDF
  • 169.38 KB
Download

Details

Authors
Abstract
BACKGROUND: CheckPoint Inhibitors (CPI) Induced arthritis (IA) is an immune related adverse event (irAEs) occurring in 0.5 to 2% of CPI-treated patients between 3 weeks up to 24 months after initiation of therapy. IA is usually described as a seronegative oligoarticular inflammatory joint disease but IA has been for long underdiagnosed and inappropriately evaluated. OBJECTIVES: To evaluate the added value of a systematic joint ultrasound assessment in these patients by the rheumatologist. […]
Affiliations

Citations

  • APA
  • Chicago
  • FWB

Meric de Bellefon, L., Aspeslagh, S., Aboubakar Nana, F., Baurain, J.-F., & Durez, P. (2023). AB1579 Ultrasound joint assessments increase detection of polyarticular joint involvement in checkpoint inhibitors induced arthritis. Annals of the rheumatic diseases, 82(Suppl 1), 2023. https://doi.org/10.1136/annrheumdis-2023-eular.3263 (Original work published 2023)